Hengelage, Thomas
Novartis (Switzerland) · Novartis Institutes for BioMedical Research
2 papers on CoChatORCID 0000-0003-1701-0232
Most cited papers
- Verified
In Vitro Studies with Purified Components Reveal Signal Recognition Particle (SRP) and SecA/SecB as Constituents of Two Independent Protein-targeting Pathways of Escherichia coli
Koch, H.-G., Hengelage, T., Neumann-Haefelin, C., MacFarlane, J., Hoffschulte, H. K., Schimz, K.-L., Mechler, B., & Müller, M. (1999) · Molecular Biology of the Cell
Bacterial Genetics and BiotechnologyRNA and protein synthesis mechanisms
Cited by 160
- Verified
Initial results from a dose finding study of TNO155, a SHP2 inhibitor, in adults with advanced solid tumors
Brana, I., Shapiro, G., Johnson, M. L., Yu, H. A., Robbrecht, D., Tan, D. S.-W., Siu, L. L., Minami, H., Steeghs, N., Hengelage, T., et al. (2021) · Journal of Clinical Oncology
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 79
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free